C94 Other leukemias of specified cell type

Name of the Condition

• Other leukemias of specified cell type
• ICD-10 Code: C94

Summary

Other leukemias of specified cell type refers to a group of malignant blood disorders characterized by the uncontrolled proliferation of specific types of white blood cells. These conditions involve abnormal cell growth in the bone marrow or blood and may affect various cell lineages, such as myeloid or lymphoid cells, depending on the subtype. If untreated, they can lead to impaired blood cell production and organ dysfunction.

Causes

The exact cause involves genetic mutations or chromosomal abnormalities in blood-forming cells, leading to uncontrolled proliferation. Contributing factors may include environmental exposures (e.g., radiation, chemicals), genetic predispositions, or prior hematologic conditions.

Risk Factors

• Prior exposure to radiation or chemotherapy
• Genetic syndromes (e.g., Down syndrome)
• Family history of leukemia
• Certain chemical exposures (e.g., benzene)
• Advanced age
• Male gender
• History of myelodysplastic syndromes

Symptoms

• Fatigue or weakness
• Unexplained weight loss
• Fever or recurrent infections
• Easy bruising or bleeding
• Bone or joint pain
• Enlarged lymph nodes, liver, or spleen
• Shortness of breath

Diagnosis

Diagnosis involves a physical examination, followed by blood tests (complete blood count, peripheral smear) to identify abnormal cell counts or morphology. A bone marrow biopsy confirms malignancy and determines the specific cell type. Additional tests (cytogenetics, flow cytometry) may classify the subtype.

Treatment Options

Treatment depends on the specific subtype, patient age, and overall health. Options include chemotherapy, targeted therapy, immunotherapy, or stem cell transplantation. Supportive care (e.g., blood transfusions, infection management) may also be necessary.

Prognosis and Follow-Up

Prognosis varies by subtype and response to treatment. Regular follow-up with blood tests and imaging monitors for recurrence or complications. Long-term survival rates depend on factors like age, disease aggressiveness, and treatment efficacy.

Complications

• Severe infections due to low white blood cell counts
• Excessive bleeding from low platelet counts
• Anemia causing fatigue or shortness of breath
• Organ infiltration (e.g., liver, spleen)
• Treatment-related side effects (e.g., nausea, organ damage)

Lifestyle & Prevention

• Avoid known carcinogens (e.g., tobacco, benzene)
• Maintain a balanced diet and regular exercise
• Practice good hygiene to reduce infection risk
• Follow medical advice for managing underlying conditions

When to Seek Professional Help

Seek care if experiencing persistent fatigue, unexplained weight loss, fever, or unusual bleeding. Prompt evaluation is critical for early diagnosis and treatment.

Tips for Medical Coders

Document the specific cell type (e.g., myeloid, lymphoid) and any relevant details (e.g., chronic vs. acute) to ensure accurate coding. Verify that the code aligns with clinical documentation and guidelines for "other leukemias of specified cell type" (C94).